JP2017512202A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512202A5
JP2017512202A5 JP2016554261A JP2016554261A JP2017512202A5 JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5 JP 2016554261 A JP2016554261 A JP 2016554261A JP 2016554261 A JP2016554261 A JP 2016554261A JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5
Authority
JP
Japan
Prior art keywords
composition
sequence
cholesterol
nucleic acid
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016554261A
Other languages
English (en)
Japanese (ja)
Other versions
JP6772065B2 (ja
JP2017512202A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/054131 external-priority patent/WO2015128461A1/en
Publication of JP2017512202A publication Critical patent/JP2017512202A/ja
Publication of JP2017512202A5 publication Critical patent/JP2017512202A5/ja
Application granted granted Critical
Publication of JP6772065B2 publication Critical patent/JP6772065B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016554261A 2014-02-28 2015-02-27 免疫賦活プラスミド Expired - Fee Related JP6772065B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461946372P 2014-02-28 2014-02-28
US61/946,372 2014-02-28
PCT/EP2015/054131 WO2015128461A1 (en) 2014-02-28 2015-02-27 Immunostimulatory plasmids

Publications (3)

Publication Number Publication Date
JP2017512202A JP2017512202A (ja) 2017-05-18
JP2017512202A5 true JP2017512202A5 (https=) 2018-04-05
JP6772065B2 JP6772065B2 (ja) 2020-10-21

Family

ID=52598746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554261A Expired - Fee Related JP6772065B2 (ja) 2014-02-28 2015-02-27 免疫賦活プラスミド

Country Status (20)

Country Link
US (2) US10155950B2 (https=)
EP (1) EP3110940A1 (https=)
JP (1) JP6772065B2 (https=)
KR (1) KR20160122849A (https=)
CN (1) CN106029867B (https=)
AU (1) AU2015222102B2 (https=)
BR (1) BR112016019837A2 (https=)
CA (1) CA2940794C (https=)
CL (1) CL2016002146A1 (https=)
CR (1) CR20160393A (https=)
DO (1) DOP2016000223A (https=)
IL (1) IL247065A0 (https=)
MX (1) MX2016010993A (https=)
PE (1) PE20170404A1 (https=)
PH (1) PH12016501705A1 (https=)
RU (1) RU2740492C2 (https=)
SV (1) SV2016005263A (https=)
UA (1) UA118374C2 (https=)
WO (1) WO2015128461A1 (https=)
ZA (1) ZA201605495B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3110940A1 (en) * 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
PE20181208A1 (es) * 2015-06-26 2018-07-23 Bayer Animal Health Gmbh Metodos de modulacion de moleculas de vigilancia de adn citosolicas
AU2016302436B2 (en) * 2015-07-31 2022-03-03 Elanco Animal Health Gmbh Enhanced immune response in porcine species
EP3328423B1 (en) * 2015-07-31 2021-05-26 Bayer Animal Health GmbH Enhanced immune response in fish
CN109689095B (zh) * 2016-07-26 2023-10-03 拜耳动物保健有限责任公司 牛物种中增加的生育力
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)
KR20200099556A (ko) * 2017-12-15 2020-08-24 바이엘 애니멀 헬스 게엠베하 면역자극성 조성물
CN109646435B (zh) * 2019-01-11 2021-08-03 山东省农业科学院奶牛研究中心 厄他培南钠在制备防治牛传染性鼻气管炎药物中的应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6645933B1 (en) * 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
US5830878A (en) 1995-06-07 1998-11-03 Megabios Corporation Cationic lipid: DNA complexes for gene targeting
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US20040247662A1 (en) 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
DE60039198D1 (de) 1999-03-26 2008-07-24 Vical Inc Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen
US20040002472A1 (en) 2000-01-21 2004-01-01 Audonnet Jean-Christophe Francis Vaccination or immunization using a prime-boost regimen
US6517218B2 (en) 2000-03-31 2003-02-11 Relume Corporation LED integrated heat sink
CA2443740A1 (en) 2001-04-24 2002-10-31 Innogenetics N.V. Constructs and methods for expression of recombinant hcv envelope proteins
CN1612749A (zh) 2001-07-02 2005-05-04 辉瑞产品公司 用于减弱牲畜体内牛支原体肺炎的猪肺炎支原体疫苗和方法
AU2002953015A0 (en) * 2002-12-02 2002-12-12 Women's And Children's Hospital Modified lacz gene
US20070134200A1 (en) 2003-03-26 2007-06-14 Wyeth Immunogenic composition and methods
EP1675614A2 (en) 2003-10-11 2006-07-05 Inex Pharmaceuticals Corp. Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
US20050181035A1 (en) 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
JP2008511545A (ja) * 2004-08-13 2008-04-17 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 抗生物質耐性欠失dnaワクチン
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
TWM297441U (en) 2006-03-30 2006-09-11 Cheng-Jiun Jian LED projection light source module
US7663229B2 (en) 2006-07-12 2010-02-16 Hong Kong Applied Science And Technology Research Institute Co., Ltd. Lighting device
AU2007314433B9 (en) * 2006-10-06 2014-02-20 The Scripps Research Institute DNA composition for eliciting an immune response against tumor-associated macrophages
US8470560B2 (en) * 2007-10-03 2013-06-25 The United States Of America As Represented By The Secretary Of The Army CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines
EP2257306B1 (en) 2008-03-25 2014-05-07 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
AU2009309041B2 (en) 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
BRPI1010803A2 (pt) * 2009-05-14 2018-06-12 Bayer Animal Health Gmbh "resposta imune aumentada na espécie aviária"
UY33821A (es) 2010-12-22 2012-07-31 Bayer Animal Health Gmbh Respuesta inmune potenciada en la especie bovina
CL2011000065A1 (es) 2011-01-11 2011-04-15 Univ Concepcion Formulacion veterinaria para la prevencion y eliminacion de infeccion por cepas de e. coli stec, que comprende un plasmido recombinante que codifica un factor de virulencia y liposoma cationico como vehiculo, uso de dicha formulacion para tratar preferentemente bovinos y porcinos.
EP3110940A1 (en) * 2014-02-28 2017-01-04 Bayer Animal Health GmbH Immunostimulatory plasmids

Similar Documents

Publication Publication Date Title
JP2017512202A5 (https=)
RU2016138321A (ru) Иммуностимулирующие плазмиды
JP7523897B2 (ja) 呼吸器合胞体ウイルス(rsv)ワクチン
Schwendener Liposomes as vaccine delivery systems: a review of the recent advances
JP4294584B2 (ja) 核酸ワクチン接種の免疫応答を高めるための方法
JP7817257B2 (ja) mRNAワクチンを送達するための脂質ナノ粒子
RU2013133730A (ru) Повышение иммунного отклика у видов крупного рогатого скота
JP2014522842A5 (https=)
JP2014520807A5 (https=)
CN101616687B (zh) 非特异性免疫刺激剂
EP4153224A1 (en) Coronavirus antigen compositions and their uses
EP4091630A1 (en) Vaccines comprising r-dotap
MXPA05013746A (es) Conjugados de esfingoide-polialquilamina para vacunacion.
US20190125858A1 (en) Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
RU2014135522A (ru) Промоторы для увеличенной экспрессии белка у менингококка
JP2018518511A5 (https=)
RU2018102915A (ru) Способы модуляции контрольных молекул цитозольной днк
US11111277B2 (en) Influenza vaccines
Lee et al. Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers
AR105568A1 (es) Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina
KR20210027168A (ko) 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물
US20230181722A1 (en) Coronavirus antigen compositions and their uses
EP3035960A2 (en) Respiratory syncytial virus (rsv) vaccine
US20240316178A1 (en) Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof
HK40083470A (en) Vaccines comprising r-dotap